Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Garber

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Nature Biotechnology|March 11, 2011
Fate of novel painkiller mAbs hangs in balanceKen Garber
Journal of the National Cancer Institute|June 26, 2010
Oncometabolite? IDH1 discoveries raise possibility of new metabolism targets in brain cancers and leukemiaKen Garber
Nature Biotechnology|August 10, 2016
Cancer anabolic metabolism inhibitors move into clinicKen Garber
Nature Biotechnology|August 10, 2016
Erratum: No longer going to wasteKen Garber
Science (New York, N.Y.)|July 11, 2015
Cancer's copper connectionsKen Garber
Nature Reviews. Drug Discovery|March 10, 2018
Tissue-agnostic cancer drug pipeline grows, despite doubtsKen Garber
Nature Biotechnology|October 12, 2017
First metabolic oncology inhibitor gets FDA green light, with record price tagKen Garber
Journal of the National Cancer Institute|February 22, 2007
New insights into oncogene addiction foundKen Garber
Science (New York, N.Y.)|November 4, 2006
Genetics. Small RNAs reveal an activating sideKen Garber
Nature Biotechnology|January 11, 2007
HDAC inhibitors overcome first hurdleKen Garber
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Nature Biotechnology|March 11, 2011
Fate of novel painkiller mAbs hangs in balanceKen Garber
Journal of the National Cancer Institute|June 26, 2010
Oncometabolite? IDH1 discoveries raise possibility of new metabolism targets in brain cancers and leukemiaKen Garber
Nature Biotechnology|August 10, 2016
Cancer anabolic metabolism inhibitors move into clinicKen Garber
Nature Biotechnology|August 10, 2016
Erratum: No longer going to wasteKen Garber
Science (New York, N.Y.)|July 11, 2015
Cancer's copper connectionsKen Garber
Nature Reviews. Drug Discovery|March 10, 2018
Tissue-agnostic cancer drug pipeline grows, despite doubtsKen Garber
Nature Biotechnology|October 12, 2017
First metabolic oncology inhibitor gets FDA green light, with record price tagKen Garber
Journal of the National Cancer Institute|February 22, 2007
New insights into oncogene addiction foundKen Garber
Science (New York, N.Y.)|November 4, 2006
Genetics. Small RNAs reveal an activating sideKen Garber
Nature Biotechnology|January 11, 2007
HDAC inhibitors overcome first hurdleKen Garber
Pageof 20